Stryker Corp (SYK): R&D Expense
$1.62B
Year ended 2025-12-31
$1.66B
Trailing 12 months to 2026-06-30
+3.7%
3-year compound annual growth
+10.5%
5-year compound annual growth
+10.0%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.62B | +10.7% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $1.47B | +5.6% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $1.39B | -4.5% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $1.45B | +17.7% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $1.24B | +25.5% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $984.00M | +1.3% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $971.00M | +12.6% | 2022-02-11, From 2019-01-01 |
| 2018-12-31 | $862.00M | +9.5% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $787.00M | +10.1% | 2020-02-06, From 2017-01-01 |
| 2016-12-31 | $715.00M | +14.4% | 2019-02-07, From 2016-01-01 |
| 2015-12-31 | $625.00M | +1.8% | 2018-02-08, From 2015-01-01 |
| 2014-12-31 | $614.00M | +14.6% | 2017-02-09, From 2014-01-01 |
| 2013-12-31 | $536.00M | +13.8% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $471.00M | +1.9% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | $462.00M | +17.3% | 2014-02-13, From 2011-01-01 |
| 2010-12-31 | $394.00M | +17.3% | 2013-02-27, From 2010-01-01 |
| 2009-12-31 | $336.00M | -8.6% | 2012-02-13, From 2009-01-01 |
| 2008-12-31 | $367.80M | -2.0% | 2011-02-18, From 2008-01-01 |
| 2007-12-31 | $375.30M | n/a | 2010-02-26, From 2007-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Stryker Corp (SYK) | 2025-12-31 | $1.62B | +10.7% |
| 3M Co (MMM) | 2024-12-31 | $700.00M | 0.0% |
| Medline Inc. (MDLN) | 2025-12-31 | $80.00M | +19.4% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $1.26B | +6.3% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $2.05B | +27.1% |
| Baxter International Inc (BAX) | 2025-12-31 | $518.00M | -12.2% |
| Solventum Corp (SOLV) | 2025-12-31 | $739.00M | -4.6% |
| ResMed Inc (RMD) | 2026-06-30 | $378.29M | +14.2% |
| Dexcom Inc (DXCM) | 2025-12-31 | $599.10M | +8.5% |
Compare SYK, MMM, MDLN, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗